| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| SANDOZ | 2020-04 | PURCHASE | 2023-10 | 884 | 727 | 157 | ||||
| LOCKHEED MARTIN | 2020-02 | PURCHASE | 2023-09 | 3,121 | 3,064 | 57 | ||||
| PRINCIPAL FINANCIAL | 2021-03 | PURCHASE | 2023-09 | 4,110 | 3,256 | 854 | ||||
| FIFTH THIRD | 2021-09 | PURCHASE | 2023-05 | 5,219 | 8,513 | -3,294 | ||||
| NOVARTIS | 2020-02 | PURCHASE | 2023-05 | 10,306 | 9,095 | 1,211 | ||||
| COMERICA | 2021-09 | PURCHASE | 2004-05 | 5,761 | 13,578 | -7,817 | ||||
| HANESBRANDS | 2022-06 | PURCHASE | 2023-02 | 9,757 | 17,395 | -7,638 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SEE ATTACHED SCHEDULE | 246,555 | 303,464 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| ADR FEES | 7 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 135 |